Trial
NCT04354428
Treatment for COVID-19 in High-Risk Adult Outpatients
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Washington
Collaborators
Bill and Melinda Gates Foundation
Condition
COVID-19
Intervention
Ascorbic Acid
Why stopped
Low number of events contributing to primary outcome
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-08